Tirzepatide raw materials purity>99%;for fitness weight loss;high quality CAS 2023788-19-2

Name:Nancy

WhatsApp:+86 15226890287

Email:nancy@xtkstech.cn

Sincerely invite you to concult

Tirzepatide is an innovative drug that demonstrates remarkable efficacy in lowering blood sugar and reducing weigh t through a unique dual-action mechanism.
The core innovation of tirzepatide lies in its dual role as a GIP and GLP-1 receptor. It can simultaneously activate two crucial intestinal hormone receptors in the human body: the GIP (glucose-dependent insulinotropic polypeptide) receptor and the GLP-1 (glucagon-like peptide-1) receptor. This dual effect can produce a synergistic effect: on the one hand, it promotes insulin secretion in a glucose concentration-dependent manner, helping to lower blood sugar; on the other hand, it acts on the brain to suppress appetite and delay gastric emptying, thereby effectively reducing food intake.
In clinical applications, Tirzepatide demonstrates remarkable efficacy. For patients with type 2 diabetes, it can significantly improve blood sugar control and reduce the level of glycosylated hemoglobin. In terms of weight management, clinical trials have shown that patients using Tirzepatide can lose up to 20% of their body weight. It is worth noting that for patients with obesity and prediabetes, the study confirmed that this drug can reduce the risk of progressing to type 2 diabetes by 93%. Additionally, the study also observed that Tirzepatide may bring cardiovascular benefits, reducing the risk of major adverse cardiovascular events.
This drug is administered by subcutaneous injection once a week, providing convenience for patients. The recommended starting dose is 2.5mg. After 4 weeks, the dose can be gradually increased based on the treatment response and tolerance, and the maintenance dose can be 5mg, 10mg or 15mg. This flexible dose adjustment plan helps to achieve individualized treatment.
The emergence of Tirzepatide represents a significant advancement in the treatment of type 2 diabetes and obesity, offering new treatment options for patients who need to improve their blood sugar control and achieve weight loss goals. Its innovative dual-action mechanism and remarkable clinical efficacy make it a major breakthrough in the field of metabolic disease treatment.

1.Helps slow food leaving your stomach
2.Helps prevent your liver from making too much sugar
3.Helps the pancreas produce more insul when your blood sugar levels are high
4.Can help control blood glucose
5.Can reduce hyperglycemia, especially after meals
6.Can reduce fasting insul and fasting glucose
7.Can reduce hemoglobin A1c
8.Can decrease appetite and caloric intake, while inhibiting weight gain
9.Has been shown to lower triglyceride levels and oxidative stress from high LDL

Hongbai Technology Co., Ltd. is  a branch of Changsha Dolo Technology Co., Ltd.，which is a pioneering force in the biotechnology sector.

At the core of our operations is the unwavering commitment to our guiding principles : "Quality First, Service Supreme."Our mission is to spearhead advancements in biotechnology by consistently upholding the highest standards of quality and service. Through innovation and excellence, we aim to contribute to the betterment of global health and well-being.

Our primary focus encompasses a range of products , including weight loss peptideses, cosmetic peptides, and customized peptides. Notable among our weight loss peptide offerings are Tirzepatide, Retatrutide, and others.Provides reliable and timely custom manufacturing services for API following stringent quality system and close communication with the Clients.We have professional sales team , focus on quality and service, and we have achieved excellent performance over the years. Our company is committed to the development of international market, our products are mainly exported to many countries and regions, such as Europe, America, South-east Asia, the Middle East and Africa etc.

With our constant efforts and good service, We sincerely hope to establish long-term cooperation and common development with our customers .

...